Ophthalmology Times2h
DMEI resident Ashley Ooms, MD, explores gray area strabismus surgery complications in AUPO poster
Ooms' poster at the Association of University Professors of Ophthalmology annual meeting highlighted a study on gray area ...
Ophthalmology Times5h
Qlaris Bio announces positive data from 2 clinical trials investigating QLS-111 in patients with primary open angle glaucoma and ocular hypertension
QLS‑111 is a novel topical formulation using Qlaris Bio’s ATP-sensitive potassium channel modulator platform. QLS-111 lowers ...
Ophthalmology Times5h
Clearside Biomedical presents new data from CLS-AX ODYSSEY phase 2b trial
The 36-week trial was a randomized, double-masked, parallel-group, active-controlled, multicenter evaluating CLS-AX (axitinib ...
Ophthalmology Times18h
Shaffer-Hetherington-Hoskins Lecture at the 2025 Glaucoma 360 meeting
M. Roy Wilson, presented the Shaffer-Hetherington-Hoskins Lecture at the Glaucoma 360 meeting held in San Francisco, ...
Ophthalmology Times20h
Regeneron reveals positive results from multiple trials evaluating Eylea HD (aflibercept) injection 8 mg
Regeneron Pharmaceuticals has announced results from the phase 3 QUASAR trial and its extension study of the phase 3 PULSAR ...